{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:24:02Z","timestamp":1717460642258},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.7759\/cureus.61552","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T05:13:01Z","timestamp":1717391581000},"source":"Crossref","is-referenced-by-count":0,"title":["A Transperineal Biopsy of the Prostate Does Not Require Routine Antibiotic Cover"],"prefix":"10.7759","author":[{"given":"David","family":"Dryhurst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullatif","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nkwam","family":"Nkwam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.312","article-title":"Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study","volume":"117","author":"Perez-Cornago A","year":"2017","unstructured":"Perez-Cornago A, Key TJ, Allen NE, Fensom GK, Bradbury KE, Martin RM, Travis RC. Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study. Br J Cancer. 2017, 117:1562-71. 10.1038\/bjc.2017.312","journal-title":"Br J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1551","article-title":"A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk","volume":"76","author":"Travis RC","year":"2016","unstructured":"Travis RC, Appleby PN, Martin RM, et al.. A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk. Cancer Res. 2016, 76:2288-300. 10.1158\/0008-5472.CAN-15-1551","journal-title":"Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0795","article-title":"Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study","volume":"23","author":"Vidal AC","year":"2014","unstructured":"Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL Jr, Freedland SJ. Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study. Cancer Epidemiol Biomarkers Prev. 2014, 23:2936-42. 10.1158\/1055-9965.EPI-14-0795","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren O","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al.. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023, 84:191-206. 10.1016\/j.eururo.2023.04.021","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001-2017","volume":"69","author":"Siegel DA","year":"2020","unstructured":"Siegel DA, O'Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001-2017. MMWR Morb Mortal Wkly Rep. 2020, 69:1473-80. 10.15585\/mmwr.mm6941a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.07.007","article-title":"Transperineal versus transrectal MRI\/Trus fusion targeted biopsy: detection rate of clinically significant prostate cancer","volume":"15","author":"Pepe P","year":"2017","unstructured":"Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal versus transrectal MRI\/Trus fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer. 2017, 15:e33-6. 10.1016\/j.clgc.2016.07.007","journal-title":"Clin Genitourin Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04003.x","article-title":"Gleason grading: past, present and future","volume":"60","author":"Delahunt B","year":"2012","unstructured":"Delahunt B, Miller RJ, Srigley JR, Evans AJ, Samaratunga H. Gleason grading: past, present and future. Histopathology. 2012, 60:75-86. 10.1111\/j.1365-2559.2011.04003.x","journal-title":"Histopathology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi M","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, et al.. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017, 71:353-65. 10.1016\/j.eururo.2016.08.004","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12536","article-title":"Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?","volume":"114","author":"Grummet JP","year":"2014","unstructured":"Grummet JP, Weerakoon M, Huang S, et al.. Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?. BJU Int. 2014, 114:384-8. 10.1111\/bju.12536","journal-title":"BJU Int"},{"key":"ref11","unstructured":"Introducing the PrecisionPoint\u00ae Transperineal Access System. (2023). Accessed. June 3, 2024: http:\/\/perineologic.com\/precisionpoint."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022, 399:629-55. 10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002251","article-title":"Infection rate after transperineal prostate biopsy with and without prophylactic antibiotics: results from a systematic review and meta-analysis of comparative studies","volume":"207","author":"Castellani D","year":"2022","unstructured":"Castellani D, Pirola GM, Law YX, et al.. Infection rate after transperineal prostate biopsy with and without prophylactic antibiotics: results from a systematic review and meta-analysis of comparative studies. J Urol. 2022, 207:25-34. 10.1097\/JU.0000000000002251","journal-title":"J Urol"},{"key":"ref14","article-title":"The antibiotic resistance crisis: part 2: management strategies and new agents","volume":"40","author":"Ventola CL","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T. 2015, 40:344-52.","journal-title":"P T"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5489%2Fcuaj.6498","article-title":"Dangerous fluoroquinolones: the urologist's dilemma","volume":"14","author":"Nickel JC","year":"2020","unstructured":"Nickel JC, Doiron RC. Dangerous fluoroquinolones: the urologist's dilemma. Can Urol Assoc J. 2020, 14:85-6. 10.5489%2Fcuaj.6498","journal-title":"Can Urol Assoc J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256064-a-transperineal-biopsy-of-the-prostate-does-not-require-routine-antibiotic-cover","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T05:13:06Z","timestamp":1717391586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256064-a-transperineal-biopsy-of-the-prostate-does-not-require-routine-antibiotic-cover"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.61552","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,2]]}}}